All In MedTech

Device Trial Radar · NCT05741333

In-Office Clinical Study of the Solo+ TTD

Pivotal In-Office Clinical Study of the Solo+ Tympanostomy Tube Device

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

66

Planned (sponsor's estimate)

Start

Mar 30, 2023

Primary completion

Mar 19, 2026

Study completion Mar 2028

Sponsor

Lead sponsor
AventaMed DACNot on our public-company list
Sponsor type
Industry
First posted
Feb 23, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 6 months, up to 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.

Conditions

  • Ear Infection
  • Otitis Media

Interventions

  • Solo+ Tympanostomy Tube Device (Solo+ TTD)Device

    The Solo+ TTD is intended to deliver a tympanostomy tube through the tympanic membrane of a patient.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Procedure SuccessTime frame: Intra-operative

1 more outcomes with a free account

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Southern Head & Neck Surgery

    Alexander City, Alabama

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.